Principal Investigator
Jaclyn Kovach
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241158
Clinical Trial Summary
A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3
Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered
Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Participants
with Geographic Atrophy Secondary to Age-Related Macular Degeneration
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Retina
Contact Information
Study Contact
Yasniel Espinosa Gonzalez
Phone Number
+1 (239) 6593962
Email
yxe82@miami.edu